blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1810715

EP1810715 - Combination comprising an agent decreasing VEGF activity and an agent decreasing EGF activity [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  26.11.2010
Database last updated on 15.06.2024
Most recent event   Tooltip26.11.2010Application deemed to be withdrawnpublished on 29.12.2010  [2010/52]
Applicant(s)For:BE  CH  CY  DE  DK  ES  FI  FR  GB  GR  IE  IT  LI  LU  MC  NL  PT  SE  TR 
Novartis AG
Lichtstrasse 35
4056 Basel / CH
For:AT 
Novartis Pharma AG
Brunner Strasse 59
1230 Vienna / AT
[N/P]
Former [2007/30]For:BE  CH  CY  DE  DK  ES  FI  FR  GB  GR  IE  IT  LI  LU  MC  NL  PT  SE  TR 
Novartis AG
Lichtstrasse 35
4056 Basel / CH
For:AT 
Novartis Pharma AG
Brunner Strasse 59
1230 Vienna / AT
Inventor(s)01 / Wood, Jeanette Marjorie
In den Kleematten 18
4105, Biel-Benken / CH
02 / Brandt, Ralf
6 Madigan Court
Greenwith, South Australia 5125 / AU
03 / Bold, Guido
Bleumatthöhe 16
5073, Gipf-Oberfrick / CH
04 / Traxler, Peter
Bündtenring 3
4124, Schönenbuch / CH
 [2007/30]
Representative(s)Graff, Alan
Novartis AG
Corporate Intellectual Property
4002 Basel / CH
[N/P]
Former [2007/30]Graff, Alan
Novartis AG Corporate Intellectual Property
4002 Basel / CH
Application number, filing date07108093.120.11.2001
[2007/30]
Priority number, dateGB2000002846722.11.2000         Original published format: GB 0028467
GB2001002181310.09.2001         Original published format: GB 0121813
[2007/30]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1810715
Date:25.07.2007
Language:EN
[2007/30]
Type: A3 Search report 
No.:EP1810715
Date:16.12.2009
[2009/51]
Search report(s)(Supplementary) European search report - dispatched on:EP17.11.2009
ClassificationIPC:A61P35/00, A61K45/06, A61K31/505, A61K31/70
[2007/30]
CPC:
A61K45/06 (EP,US); A61K31/505 (EP,US); A61K31/70 (EP,US);
A61P1/16 (EP); A61P13/12 (EP); A61P25/28 (EP);
A61P27/02 (EP); A61P29/00 (EP); A61P3/10 (EP);
A61P35/00 (EP); A61P35/02 (EP); A61P35/04 (EP);
A61P37/06 (EP); A61P43/00 (EP); A61P9/10 (EP);
A61P9/12 (EP) (-)
C-Set:
A61K31/505, A61K2300/00 (US,EP);
A61K31/505, A61K31/50 (US,EP);
A61K31/505, A61K31/50, A61K31/335 (US,EP);
A61K31/70, A61K2300/00 (EP,US);
A61K31/70, A61K31/505, A61K31/50 (EP,US)
(-)
Designated contracting states[2010/34]
Former [2007/30]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE,  TR 
TitleGerman:Kombination enthaltend ein Mittel zur Verringerung von VEGF-Aktivität und ein Mittel zur Verringerung von EGF-Aktivität[2007/30]
English:Combination comprising an agent decreasing VEGF activity and an agent decreasing EGF activity[2007/30]
French:Combinaison comprenant un agent pour diminuer l'activité du VEGF et un agent pour diminuer l'activité du EGF[2007/30]
Examination procedure17.06.2010Application deemed to be withdrawn, date of legal effect  [2010/52]
26.07.2010Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2010/52]
Parent application(s)   TooltipEP01997301.5  / EP1339458
Fees paidRenewal fee
11.09.2007Renewal fee patent year 03
11.09.2007Renewal fee patent year 04
11.09.2007Renewal fee patent year 05
11.09.2007Renewal fee patent year 06
15.11.2007Renewal fee patent year 07
31.03.2008Renewal fee patent year 08
12.11.2009Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[DXA]WO9702266  (CIBA GEIGY AG [CH], et al) [DX] 1-5,7,9,10,14,16-19 * page 9, paragraph 5 - page 10, paragraph 3 * * page 6, paragraph 3; example 22E; claims 11,16-18 * [A] 11-13;
 [DXA]WO9835958  (CIBA GEIGY AG [CH], et al) [DX] 1-6,9,10,14-19 * page 15, paragraph 6 - page 16, paragraph 2; example 62; claims 1,12-15 * * page 1, paragraphs 1-3 * [A] 11-13;
 [X]WO9902532  (NOVARTIS AG [CH], et al) [X] 1,4,9-11,14,16-19 * page 2, paragraph 2 * * page 28, paragraph 2 * * page 28, paragraph 4 - page 29, paragraph 1 * * page 22, paragraph 2 *;
 [X]WO0000206  (UNIV GEORGETOWN [US]) [X] 1,4,9-11,14,16-19 * page 13, lines 8-15; claims 26-28 * * page 36, lines 3-7 * * page 37, lines 22-25 *;
 [DX]WO0059509  (NOVARTIS AG [CH], et al) [DX] 1-6,9-11,14-19 * page 26, paragraphs 2,3 * * page 27, paragraph 1 * * page 60, paragraph 3; claims 29-32 *;
 [PX]WO0147507  (NOVARTIS AG [CH], et al) [PX] 1-7,9,10,14-19 * page 20, paragraph 4 ** pages 12-20 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.